OPKO Health, Inc. 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-07 7:49 pm Purchase | 2026-07-31 | 13D | COCRYSTAL PHARMA INC PAR $ COCP | OPKO HEALTH, INC. OPK | 5,692,916 29.600% | 5,384,995 (+1748.82%) | Filing |